RelA/NFkB p65 [p Ser529] Blocking Peptide Summary
A blocking peptide from human RelA/NFkB p65.
Source: Synthetic
p Ser529
Blocking Peptide
RELA
>95%, by HPLC
Applications/Dilutions
This phospho-control peptide for NBP1-77808 should be used at 1.0 ug per 1.0 ul of antiserum in per assay.
Packaging, Storage & Formulations
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
0.01% Sodium Azide
1.0 mg/ml
>95%, by HPLC
Alternate Names for RelA/NFkB p65 [p Ser529] Blocking Peptide
- MGC131774
- nf kb p65
- NFkB p65
- NF-kB p65
- NFKB3
- NFKB3v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor ofkappa light polypeptide gene enhancer in B-cells 3 (p65))
- Nuclear factor NF-kappa-B p65 subunit
- Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3transcription factor p65
- p65
- p65RelA
- rela p65
- RelA
- v-rel reticuloendotheliosis viral oncogene homolog A (avian)
- v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappalight polypeptide gene enhancer in B-cells 3, p65
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.
product targets :　Sodium Channel inhibitors